Zydus Cadila looks to complete clinical trials of its COVID-19 vaccine in 7 months
Drug firm Zydus Cadila is looking to complete clinical trials of its COVID-19 vaccine candidate ZyCoV-D in seven months, the company's chairman said on Friday.
Depending on the study outcomes and if the data is encouraging and the vaccine is found to be effective during the trials, it could take a total of seven months for the trials to be completed and for the vaccine to be launched, he added.
The aim would be to cater to the India market first, Patel said.
Earlier this month, Zydus had received approval from the national drug regulator to initiate human trials for its COVID-19 vaccine contender.
With a record single-day surge of 34,956 cases, India's COVID-19 tally zoomed past ten lakh on Friday, just three days after it crossed the nine-lakh mark, according to the Union Health Ministry data.
Comments
Post a Comment